Publicaciones en las que colabora con Sara Cantisán (12)

2019

  1. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment

    Clinical Microbiology and Infection, Vol. 25, Núm. 3, pp. 381.e1-381.e10

2018

  1. Lack of evidence of association between IFNG and IL28B polymorphisms and QuantiFERON-CMV test results in seropositive transplant patients

    Human Immunology, Vol. 79, Núm. 6, pp. 499-505

2017

  1. Impact of age and cytomegalovirus on CD8+ T-cell compartment remodeling after solid organ transplantation: A one-year follow-up study

    Experimental Gerontology, Vol. 95, pp. 98-106

2016

  1. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 30, Núm. 3, pp. 119-143

  2. Prevention strategies differentially modulate the impact of cytomegalovirus replication on CD8+ T-cell differentiation in high-risk solid organ transplant patients

    Antiviral Research, Vol. 132, pp. 244-251

2015

  1. Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates

    American Journal of Transplantation, Vol. 15, Núm. 3, pp. 715-722

  2. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

    Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18

  3. Pre-transplant thymic function is associated with the risk of cytomegalovirus disease after solid organ transplantation

    Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 511.e1-511.e7

2013

  1. Impact of cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 68, Núm. 1, pp. 1-5

  2. Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation

    American Journal of Transplantation, Vol. 13, Núm. 3, pp. 738-745

2011

  1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758

2010

  1. CD45RA expression on HCMV-specific effector memory CD8+ T cells is associated with the duration and intensity of HCMV replication after transplantation

    Clinical Immunology, Vol. 137, Núm. 1, pp. 81-88